Pharmamarketeer

US FDA approves Kyowa Kirin’s Nourianz tablets as new add─on drug to treat off episodes in adults with Parkinson’s disease

The US Food and Drug Administration (FDA) approved Nourianz (istradefylline) tablets as an add─on treatment to levodopa/ carbidopa in adult patients with Parkinson’s disease (PD) experiencing “off” episodes.

Medhc-fases-banner
Advertentie(s)